1. Assessment of chemotherapy-associated nephrotoxicity in children with cancer

   • Roderick Skinner
   • Andrew D. J. Pearson
   • Alan W. Craft

   Review Pages: 81 - 92

2. Membrane glycoprotein changes associated with anthracycline resistance in HL-60 cells

   • James E. Gervasoni Jr
   • Robert N. Taub
   • Alexander A. Hindenburg

   Original Articles Pages: 93 - 101

3. Role of protein kinase C in Adriamycin-induced erythroid differentiation of K562 cells

   • Richard Hoffman
   • Edward S. Newlands

   Original Articles Pages: 102 - 104

4. Multivesicular liposomes containing bleomycin for subcutaneous administration

   • Romi Roy
   • Sinil Kim

   Original Articles Pages: 105 - 108

5. High mitomycin C concentration in tumour tissue can be achieved by isolated liver perfusion in rats

   • Andreas Marinelli
   • Dirk H. A. Pons
   • Cornelis J. H. van de Velde

   Original Articles Pages: 109 - 114

6. Growth-inhibitory effects of 5,10-dideazatetrahydrofolic acid on variant murine L1210 and human CCRF-CEM leukemia cells with different membrane-transport characteristics for (anti)folate compounds

   • Gerrit Jansen
   • G. Robbin Westerhof
   • Jan H. Schornagel

   Original Articles Pages: 115 - 117

7. Lack of stereoselectivity in the pharmacokinetics and metabolism of the radiosensitizer Ro 03-8799 in man

   • Paul Workman
   • Hugh F. V. Newman
   • Carey E. Smithen

   Original Articles Pages: 118 - 122

8. A mathematical model of the kinetics of 5-fluorouracil and its metabolites in cancer patients

   • Christine Coustère
   • France Mentré
   • Jean-Louis Steimer

   Original Articles Pages: 123 - 129

9. Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology

   • M. Hassan
   • G. Öberg
   • B. Simonsson

   Original Articles Pages: 130 - 134

10. m-BACOD chemotherapy for intermediate- and high-grade non-Hodgkin's lymphoma

    • Raymond Liang
    • Edmond Chiu
    • Faith Ho

    Original Articles Pages: 135 - 138

11. Sequential chemotherapy in good-prognosis patients with small-cell lung cancer

    • C. J. Twelves
    • J. Goldman
    • D. Geddes

    Original Articles Pages: 139 - 141

12. A phase II study of ifosfamide and a_2b-interferon in advanced non-small-cell lung cancer

    • M. J. Lind
    • S. Gomm
    • N. Thatcher

    Original Articles Pages: 142 - 144

13. Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872

    • A. S. Th. Planting
    • A. Ardizzoni
    • J. G. McVie

    Short Communication Pages: 145 - 146

14. Mitomycin C, teniposide, and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung

    • Giuseppe Giaccone
    • Valter Iberti
    • Franco Testore

    Short Communication Pages: 147 - 149

15. Acetazolamide for alkalinisation of urine in patients receiving high-dose methotrexate

    • Jonathan Shamash
    • Helena Earl
    • Robert Souhami

    Short Communication Pages: 150 - 151

16. Meeting announcement

    Announcement Pages: 152 - 152